Mexico Continues Reliance Strategy To Expand Drug Access
Mexico aims to speed up the registration of generics and biosimilars.
You may also be interested in...
Moves to widen GMP certificate recognition are in line with World Health Organization recommendations on Good Reliance Practices and with the Mexican government’s strategy for regulatory certainty for the pharmaceutical sector, says the country’s drugs regulator.
The scheme still includes high rebate rates, but a controversial life cycle adjustment mechanism has been dropped.
The pharmaceutical legislation overhaul offers some solutions to the problem of immature applications.